Navigation Links
Royal DSM and JLL create leading pharma services company in USD 2.6 bn transaction
Date:11/18/2013

al value. With this partnership DSM has made a key step in the strategic transformation of its Pharma activities into partnerships whilst creating maximal value for all stakeholders."

Paul S. Levy, Managing Director of JLL Partners, Chairman of the Board of Patheon shared: "This partnership demonstrates JLL's commitment to building companies that create value, fill unmet needs and drive excellence within their respective industries. This is the strategic initiative and execution 'know how' that stakeholders have come to expect from JLL. NewCo is poised to transform the CDMO industry and we are excited to bring these two entities together."

Stefan Doboczky, Member of the DSM Managing Board and responsible for the Pharma cluster,  commented: "Our customers bring life-saving and life-enhancing medicines to people who need them around the world. They will greatly benefit from NewCo's unmatched depth and breadth of capabilities and services. I am convinced that NewCo will be even better positioned to help customers succeed with their unique needs."

Financial information
DSM expects the transaction to be accretive to its earnings per share from 2015 onwards. In accordance with the applicable accounting standards DPP will be classified as assets held for sale in Q4 2013 and a non-cash impairment loss of around €120 million will be recognized as an exceptional item. From the closing date onwards DSM will present the investment in NewCo as an associated account in accordance  with the equity method. Under IFRS rules also DSM Sinochem Pharmaceuticals will be deconsolidated from 1 January 2014. Consequently, the reporting of the Pharma cluster in the core EBITDA of DSM will be discontinued from the beginning of 2014.
'/>"/>

SOURCE Royal DSM
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. AcelRx Pharmaceuticals Hires Mike A. Royal, M.D. as Chief, Clinical Affairs
2. Royalty Rates Take Center Stage in Biopharma Dealmaking
3. Home Affairs Committees Drugs Report: Angelus Foundation Says the Prime Minister Should Not Have Rejected a Royal Commission
4. NeuroSigma Invited to Present an Overview of eTNS for the Treatment of Epilepsy and Depression at The Royal Society of Medicine in London
5. Royalty Pharma Announces Proposal To Acquire Elan
6. PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
7. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
8. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
9. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
10. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
11. Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. ... Biotechnology, Inc. for the compounding, packaging and distributing of its ... the United States . ... of compounding naltrexone tablets in various strengths for individual patients ...
(Date:1/23/2015)... 23, 2015  iMD Companies, Inc. (ICBU) has repositioned itself as ... and grab a foothold in the hydroponic, hemp and medical ... a presence in the sector, and recently partnering with the ... hemp and medical marijuana, iMD is committing to bring its ...
(Date:1/23/2015)... , Jan. 23, 2015  Mallinckrodt plc (NYSE: ... has approved a share repurchase program. The open-ended authorization ... of Mallinckrodt plc ordinary shares. "Funding ... top priorities as we continue to pursue a range ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
... - 12-week study concludes that new cosmeceutical improves skin ... Calif., May 4 Senetek PLC (OTC ... the development of technologies that target the science of ... "Topical PRK-124 (0.125%) Lotion for Improving the Signs and ...
... Experience Significant Improvement in Ocular Surface Disease and Quality ... Inc. announced today that results from a large (n ... ophthalmic insert will be presented this week during the ... Vision and Ophthalmology (ARVO), May 3-7, Ft. Lauderdale, FL, ...
Cached Medicine Technology:Spotlight on Rosacea Advance - May Issue of Journal of Drugs in Dermatology Features Pyratine XR(TM) Clinical Study 2ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; 2ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; 3ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; 4ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; 5
(Date:1/22/2015)... DC (PRWEB) January 22, 2015 Payday ... in vulnerable communities and cause financial distress to the ... by analysts at Howard University’s Center on Race and ... dollars in economic activity, payday loans at the same ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 As ... of overall health care gains momentum worldwide, Rev. Eric ... HealthCare Chaplaincy Network (HCCN), will be the keynote ... spiritual care in Israel’s public health system. , The conference, ...
(Date:1/22/2015)... released a new blog post presenting a list of vehicles that ... , Some types of vehicles cannot be covered under an ordinary ... to see if their vehicle qualifies for auto insurance coverage. ... cars that cannot be covered by a plan. Clients have little ...
(Date:1/22/2015)... VA (PRWEB) January 22, 2015 Step ... power at the Science Museum of Virginia. Wicked Plants, ... , Wicked Plants unearths 75 poisonous, carnivorous and diabolical ... through each room to uncover the biochemical, physical and ...
(Date:12/26/2014)... The US represents the largest market for CRC across ... estimates that sales of branded therapies were $2.23 billion. The ... incidence of the disease, high drug treatment rate, and higher ... sales of CRC therapies over the forecast period will be ...
Breaking Medicine News(10 mins):Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... Executive Director, Campaign for,Tobacco-Free Kids, WASHINGTON, July ... a truly historic vote to protect children from,tobacco ... the U.S. Food and Drug Administration authority to ... House has ever approved such,legislation. Today,s vote by ...
... SAN DIEGO, July 30 BioMed Realty Trust, Inc.,(NYSE: BMR ... the life science industry, today announced financial results for,the second quarter ... operations (FFO) for the quarter were $34.5 million, or ... transactions during the quarter representing gross leasing ...
... Record High, BEDFORD, Mass., July 30 ... technologies company specializing in,diagnostics, imaging products and interventional ... today announced its results for the,quarter ended June ... -- Revenues of $429.5 million., -- ...
... DOVER, N.H., July 30 The U.S. House of,Representatives ... grant the U.S. Food and Drug Administration (FDA) authority ... tobacco,marketing and sales to kids. The bill passed with ... goes to the U.S. Senate for,consideration. Senator Judd Gregg ...
... ATLANTA, July 30 J.D. Power and Associates,announced ... Member,Satisfaction among Commercial Health Plans in the South ... Plan Study(SM)., This is the first J.D. ... The J.D. Power and Associates study evaluated seven ...
... it promotes growth of healthy tissue after heart attack , , ... to regenerate cardiac muscle damaged by a heart attack or ... human trials. , The patch is made of vicryl, a ... by the body, explained Jordan J. Lancaster, a predoctoral fellow ...
Cached Medicine News:Health News:U.S. House Casts Historic Vote to Protect Kids from Tobacco, Save Lives; Senate Should Act This Year and President Should Sign Bill Into Law 2Health News:U.S. House Casts Historic Vote to Protect Kids from Tobacco, Save Lives; Senate Should Act This Year and President Should Sign Bill Into Law 3Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 2Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 3Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 4Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 5Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 6Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 7Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 8Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 9Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 10Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 11Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 12Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 13Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 2Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 3Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 4Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 5Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 6Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 7Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 8Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 9Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 10Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 11Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 12Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 13Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 14Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 15Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 16Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 17Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 18Health News:House Passes Historic Bill to Protect Kids From Tobacco; Senator Sununu Should Cosponsor Legislation 2Health News:J.D. Power and Associates Study Ranks Kaiser Permanente Highest in Member Satisfaction in South Atlantic Region 2Health News:Patch Helps Mend Damaged Hearts 2
Size: Medium. 22.50 mm by 24.00 mm. Clear lucite. Supplied sterile....
... 3.0 x 7.5 x 80 mm. ... II line designed by Harvey A. ... a closed cell sponge which is ... with rounded edges to minimize scleral ...
... x 7.5 x 80 mm. Storz ... line designed by Harvey A. Lincoff, ... closed cell sponge which is non-toxic ... rounded edges to minimize scleral intrusion. ...
Thin silicone pad implant. Indications: For closing scleral ruptures. Overall length: 7.8 mm....
Medicine Products: